"The landmark results of the IMPACT trial suggest a window of opportunity in early childhood to induce remission of peanut allergy through oral immunotherapy."
Study to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis as well as biological pathways that lead to these conditions.